Jumawid, Essyll Briallyn C.

HRN: 23-79-57  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/07/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
08/07/2025
08/14/2025
IV
250mg
Q6hours
PCAP-C
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines